Ledger.Open graph →
SEC Form D · Amendment · filed September 23, 2020

Finch Therapeutics Group, Inc

Offering
$90.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOMERVILLE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Carter G. Mcnabb · Louisville, CODirectorJames Burgess · Somerville, MAExecJo A. Viney · Somerville, MADirectorChris Lange · Somerville, MADirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMichael Galgon · Seattle, WADirectorAlexander T. Edwards · Boston, MAExecSheryl Elsdon · Vancouver, British Columbia, CanadaDirectorZain Kassam · Somerville, MAExecLei Xu · San Francisco, CADirectorAndrew Mulderry · Somerville, MADirectorKerry Song · San Clemente, CAExecJackie N. Charlesworth · Hong Kong, Hong KongDirectorRuoyu Wang · San Francisco, CADirectorDomenic Ferrante · Somerville, MADirectorChristopher A. Cosmides · Somerville, MADirectorPatrick Dunn · PROVIDENCE, RIExecMarc N. Puglia · PROVIDENCE, RIExecJeffery A. Smisek · Somervlle, MADirectorAllison Harr · Seattle, WADirectorBracken T. Darrell · Boston, MAExec · DirectorAndrew Noh · Somerville, MAExecBenjamin Enerson · Somerville, MAExecGabriel Haddad Silva · Grand Cayman, Cayman IslandsDirectorMark Smith · Somerville, MAExec · DirectorRichard G. Schultze · Plano, TXDirectorHarry W. Lengsfield · NEW YORK, NYExecMilton Berlinski · New York, NYDirectorShane Slominski · Minnetonka, MNDirectorTodd Haskins · New York, NYExecPeter Aberg · New York, NYDirectorDavid T. Sinclair · Boston, MAExecLair G. Kennedy · Louisville, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗